Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

Stock futures are mixed Thursday morning as the market takes a breather from a rally that has pushed major indexes back near record high levels.

Montaka Global Investments, an investment management company, released its fourth quarter 2024 investor letter. A copy of the ...

These companies have an inside track on high-growth markets, including artificial intelligence, quantum computing, and more.

The country’s Competition and Markets Authority is investigating mobile ecosystems controlled by Apple and Alphabet’s Google ...

The Google stock price has jumped to a record high this year. Alphabet has become the cheapest company in the Magnificent 7 ...

Inc. faces a complex landscape of opportunities and challenges as it navigates the evolving tech industry. While regulatory ...

Google might have just invested another billion dollars into Anthropic, who is one of the main rivals of OpenAI.

We recently published a list of 10 AI News Making Waves on Wall Street. In this article, we are going to take a look at where ...

Google is deepening its partnership with Anthropic after it invested an additional $1 billion in the AI startup, a contender of ChatGPT maker OpenAI.

Alphabet Inc. consistently surpasses the Rule of 40, with a current score of 42.8, showcasing an excellent balance of growth ...

So-called Big Tech stocks with outsized weightings in the S&P 500 were rising sharply Wednesday, with gains led by Nvidia Corp. The Roundhill Magnificent Seven ETF, whose portfolio equally weights ...